Results
|
21.
|
|
|
22.
|
|
|
23.
|
|
|
24.
|
|
|
25.
|
|
|
26.
|
|
|
27.
|
|
|
28.
|
|
|
29.
|
|
|
30.
|
|
|
31.
|
|
|
32.
|
|
|
33.
|
|
|
34.
|
Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors. [electronic resource] by
- Fisher, B
- Dignam, J
- Bryant, J
- DeCillis, A
- Wickerham, D L
- Wolmark, N
- Costantino, J
- Redmond, C
- Fisher, E R
- Bowman, D M
- Deschênes, L
- Dimitrov, N V
- Margolese, R G
- Robidoux, A
- Shibata, H
- Terz, J
- Paterson, A H
- Feldman, M I
- Farrar, W
- Evans, J
- Lickley, H L
Producer: 19961204
In:
Journal of the National Cancer Institute vol. 88
Availability: No items available.
|